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age (1.9 [1.85—1.94], P < 0.001) and dyslipidemia (3.3 [1.22—8.22],
P < 0.001) were the independent factors associated with AS (Fig. 1).
Conclusions Commissural fusion of aortic cusps is associated
with BAV dysfunction. By altering aortic blood flow and stiffen-
ing fused leaflet, the raphe could accelerate valve degeneration.
These results suggested the emerging role of mechanobiology in
BAV degeneration.
Figure 1 Aortic valve function regarding valve phenotype in 223
patients with BAV.
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Objectives We sought to evaluate and compare both the prognos-
tic value of acceleration time (AT) and the ratio of AT to ejection
time (AT/ET) in aortic stenosis (AS).
Background Ejection dynamics parameters are useful in assessing
prosthetic valve obstruction but very limited data are available in
the setting of native AS.
Methods AT and AT/ET were measured in a prospective cohort
of patients with aortic stenosis (AVA < 1.3 cm2). The relation-
ships between AT/ET, AT, overall and cardiovascular mortality during
follow-up were studied.
Results Four hundred and fifty-six patients with AS (mean AVA
0.85 ± 0.24 cm2) were included. After adjustment on variables
of prognostic importance and on AVR as a time-dependent covari-
ate, patients in the highest tertile of both AT/ET (> 0.36) and AT
(> 112 ms) were at high risk of overall mortality (HR 2.57 [1.68—3.94]
and HR 2.06 [1.33—3.18] respectively) and of cardiovascular mor-
tality (HR 3.33[1.78—6.21] and HR 2.36[1.30—4.30] respectively),
compared to patients in the lowest tertiles of AT/ET and AT, while
the survival was similar for the other tertiles (all P values = NS).
Compared to patients with an AT/ET≤ 0.36, an increased risk
of overall and cardiovascular mortality was observed in patients
with AT/ET > 0.36 (adjusted HR 2.55 [1.79—3.62] and adjusted
HR 3.40 [2.05—5.64] respectively). Compared to patients with an
AT≤ 112 ms, an increased risk of overall and cardiovascular mor-
tality was observed in patients with AT > 112 ms (adjusted HR 1.75
[1.21—2.53] and adjusted HR 2.23[1.34—3.71] respectively). How-
ever, AT/ET showed better predictive performance than AT in terms
of both overall and cardiovascular mortality with improved global
model fit, reclassification, and better discrimination.
Conclusion Ejection dynamics parameters in AS, particularly
AT/ET, are strongly associated with an excess risk of death dur-
ing follow-up. AT/ET should be considered in the multi-parametric
echocardiographic prognostic assessment of AS in clinical practice.
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To assess the long-term outcome of patients with an enlarged
ascending thoracic aorta (ATA), a retrospective study was per-
formed.
Methods Inclusion criteria: ATA diameter of 38 mm or more by ETT
(813 consecutive cases). Inclusion period: 01.1.2003—31.12.2016.
Results At baseline, the mean diameter of the ATA was
42 ± 3 mm, the mean Z-score was 2.7 ± 0.8. Six years later, the
mean diameter was 41.9 ± 4.8 mm, the mean Z-score 2.4 ± 1.1. Dur-
ing the follow-up, 52 patients had an intervention on the ATA, 22
patients were operated within the first 3 months after the diagnos-
tic echocardiogram. In the 791 remaining patients (without early
intervention), the event rate (death, intervention on the ATA) was
assessed by the competing risk model. In the group of patients with
a baseline ATA diameter of less than 41 mm (Group A: n = 254), the
cumulative incidence of death at 5 and 10 y was 34% and 61%; in
the group of patients with an ATA diameter of 41—42 mm (Group B:
n = 238) the incidence was 34% and 61% respectively, in the group of
patients with an ATA diameter of 43-44 mm (Group C: n = 147), the
incidence was 32% and 58%, in the group of patients with a diameter
of 45 and more (Group D: n = 150), the incidence was 31.1% and 61%
(NS). The cumulative incidence of intervention at 5 and 10 years
was 0.4% and 1% in group A, 1.3 and 1.8% in group B, 0.7 and 1.4%
in group C and 9.8 and 12.9% in group D (P < 0.05). Similar results
were observed in patients according to the Z-scores. In the group
of patients (221) with a Z-score > 3, the incidence of intervention
at 5 and 10 y was respectively 7.6% and 10.7% (P = 0.01).
Conclusions The diameter of the enlarged ATA remained nearly
unchanged over a period of 6 years. No impact of the enlarged ATA
on survival was observed. Only patients with an ATA diameter of
45 mm and more (or a Z-score of 3 and more) needed an interven-
tion at a rate of ±10% at 10 y after the initial echocardiographic
diagnosis.
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